Regis NU 643 Module 7 (Latest 2024) Questions With Complete Grade A+ Answers

Regis NU 643 Module 7 (Latest 2024) Questions With Complete Grade A+ Answers Suicide Risk - answer FDA Black box warning on anticonvulsants DRESS - multi organ hypersensitivity reaction syndrome - answer Adverse side effect characterized by rare occurrence of rash, fever, lymphadenopathy Carbamazepine - answer Mood stabilizer with potential for significant drug-drug interactions Carbamazepine - answer Mood stabilizer that carries risk of hematologic abnormalities Lamotrigine - answer Mood stabilizer with black box warning for skin reactions, including Stevens Johnson Lamotrigine - answer Mood stabilizer initiated with slow upward dose titration Lithium - answer Mood stabilizer metabolized by kidneys CBC and LFT at baseline, 6weeks, q3 mos - answer Lab monitoring for Carbamazepine TSH/T4, BUN/Cr, electrolytes, Lithium level at wk, 1-2 mos and q6-12mos - answer Lab monitoring for Lithium Lithium - answer Mood stabilizer known for anti-suicide effects Oxcarbazepine - answer Mood stabilizer considered second line to lithium and valprioc acid Carbamazepine - answer Mood stabilizer with risk for skin reactions (but without black box warning) Valproic Acid - answer Mood stabilizer with risk of hepatotoxicity Valproic Acid - answer Mood stabilizer with risk for polycystic ovary disease LFTs, CBC with platelets at baseline, q6mos - answer Routine lab monitoring for valproic acid Lithium, Valproic Acid, Tegretal (usually) - answer Mood stabilizers dosed to therapeutic blood level Lithium - answer Mood stabilizer with long-term adverse effects on thyroid and kidneys Benzodiazepines - answer Medication class used adjunctively to treat agitation, insomnia and incipient manic symptoms Topiramate - answer Novel Anticonvulsant Used off label for bipolar disorder Topiramate - answer Anticonvulsant with dose related cognitive side effects